Hinge Health, Inc.

Rank #61Hypergrowth

HNGE · NYSE · Healthcare

Hinge Health, Inc. (HNGE) — Rank #61 by gross profitability (GP/assets 0.57) · ROE -153.4% · Piotroski F-Score 4 / 9.

As-of 2026-09-15 · CIK 0001673743 · all metrics point-in-time as of the filing date.

About

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology.

It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers.

The company was founded in 2012 and is headquartered in San Francisco, California.

Industry: Health Information Services
Sector: Healthcare
State: DE
Filer Category: Emerging growth company
Fiscal Year End: December 31
Website: hingehealth.com

Financials

Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.

USD in millions, except per-share (EPS) and percentage rows. Values are as originally filed; em-dash = not tagged in that year's filing.
Fiscal year end	2025-12-31filed 2026-03-03	2024-12-31filed 2026-03-03	2023-12-31filed 2026-03-03
Operating
Depreciation & amortization	5.1	6.0	5.6
Stock-based compensation	643.0	0.7	1.6
Change in receivables	26.6	1.3	23.1
Change in inventory	4.8	(0.6)	(10.6)
Operating cash flow	171.4	49.0	(63.9)
Investing
Capital expenditures	0.7	—	—
Investing cash flow	(113.8)	18.3	1.5
Financing
Share repurchases	65.0	0.0	0.0
Financing cash flow	(150.5)	(2.2)	(3.0)
Summary
Free cash flow	170.7	170.7	170.7

Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?